Literature DB >> 28604749

Cystine addiction of triple-negative breast cancer associated with EMT augmented death signaling.

X Tang, C-K Ding, J Wu, J Sjol, S Wardell, I Spasojevic, D George, D P McDonnell, D S Hsu, J T Chang, J-T Chi.   

Abstract

This corrects the article DOI: 10.1038/onc.2016.394.

Entities:  

Year:  2017        PMID： 28604749     DOI： 10.1038/onc.2017.192

Source DB:  PubMed          Journal:  Oncogene        ISSN： 0950-9232            Impact factor:   9.867


  12 in total

1.  A TAZ-ANGPTL4-NOX2 Axis Regulates Ferroptotic Cell Death and Chemoresistance in Epithelial Ovarian Cancer.

Authors:  Wen-Hsuan Yang; Zhiqing Huang; Jianli Wu; Chien-Kuang C Ding; Susan K Murphy; Jen-Tsan Chi
Journal:  Mol Cancer Res       Date:  2019-10-22       Impact factor: 5.852

2.  Kinome screen of ferroptosis reveals a novel role of ATM in regulating iron metabolism.

Authors:  Po-Han Chen; Jianli Wu; Chien-Kuang Cornelia Ding; Chao-Chieh Lin; Samuel Pan; Nathan Bossa; Yitong Xu; Wen-Hsuan Yang; Bernard Mathey-Prevot; Jen-Tsan Chi
Journal:  Cell Death Differ       Date:  2019-07-18       Impact factor: 15.828

3.  Integrated RNA and DNA sequencing reveals early drivers of metastatic breast cancer.

Authors:  Marni B Siegel; Xiaping He; Katherine A Hoadley; Alan Hoyle; Julia B Pearce; Amy L Garrett; Sunil Kumar; Vincent J Moylan; Claudia M Brady; Amanda Ed Van Swearingen; David Marron; Gaorav P Gupta; Leigh B Thorne; Niamh Kieran; Chad Livasy; Elaine R Mardis; Joel S Parker; Mengjie Chen; Carey K Anders; Lisa A Carey; Charles M Perou
Journal:  J Clin Invest       Date:  2018-02-26       Impact factor: 14.808

4.  RIPK3 upregulation confers robust proliferation and collateral cystine-dependence on breast cancer recurrence.

Authors:  James V Alvarez; Jen-Tsan Chi; Chao-Chieh Lin; Nathaniel W Mabe; Yi-Tzu Lin; Wen-Hsuan Yang; Xiaohu Tang; Lisa Hong; Tianai Sun; Jeremy Force; Jeffrey R Marks; Tso-Pang Yao
Journal:  Cell Death Differ       Date:  2020-01-27       Impact factor: 15.828

5.  Glycosylation of KEAP1 links nutrient sensing to redox stress signaling.

Authors:  Po-Han Chen; Timothy J Smith; Jianli Wu; Priscila F Siesser; Brittany J Bisnett; Farhan Khan; Maxwell Hogue; Erik Soderblom; Flora Tang; Jeffrey R Marks; Michael B Major; Benjamin M Swarts; Michael Boyce; Jen-Tsan Chi
Journal:  EMBO J       Date:  2017-06-29       Impact factor: 11.598

6.  The influence of low-carbohydrate diets on the metabolic response to androgen-deprivation therapy in prostate cancer.

Authors:  Jen-Tsan Chi; Pao-Hwa Lin; Vladimir Tolstikov; Taofik Oyekunle; Gloria C G Alvarado; Adela Ramirez-Torres; Emily Y Chen; Valerie Bussberg; Bo Chi; Bennett Greenwood; Rangaprasad Sarangarajan; Niven R Narain; Michael A Kiebish; Stephen J Freedland
Journal:  Prostate       Date:  2021-05-05       Impact factor: 4.012

7.  Serum metabolomic analysis of men on a low-carbohydrate diet for biochemically recurrent prostate cancer reveals the potential role of ketogenesis to slow tumor growth: a secondary analysis of the CAPS2 diet trial.

Authors:  Jen-Tsan Chi; Pao-Hwa Lin; Vladimir Tolstikov; Lauren Howard; Emily Y Chen; Valerie Bussberg; Bennett Greenwood; Niven R Narain; Michael A Kiebish; Stephen J Freedland
Journal:  Prostate Cancer Prostatic Dis       Date:  2022-03-25       Impact factor: 5.455

8.  DEK promoted EMT and angiogenesis through regulating PI3K/AKT/mTOR pathway in triple-negative breast cancer.

Authors:  Yang Yang; Meihua Gao; Zhenhua Lin; Liyan Chen; Yu Jin; Guang Zhu; Yixuan Wang; Tiefeng Jin
Journal:  Oncotarget       Date:  2017-10-17

Review 9.  The Intersection of DNA Damage Response and Ferroptosis-A Rationale for Combination Therapeutics.

Authors:  Po-Han Chen; Watson Hua-Sheng Tseng; Jen-Tsan Chi
Journal:  Biology (Basel)       Date:  2020-07-23

10.  Metabolomic effects of androgen deprivation therapy treatment for prostate cancer.

Authors:  Jen-Tsan Chi; Pao-Hwa Lin; Vladimir Tolstikov; Taofik Oyekunle; Emily Y Chen; Valerie Bussberg; Bennett Greenwood; Rangaprasad Sarangarajan; Niven R Narain; Michael A Kiebish; Stephen J Freedland
Journal:  Cancer Med       Date:  2020-03-31       Impact factor: 4.452
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.